PLRZ
Polyrizon Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$11.24
−10.51%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-15.9%
Return on equity
-15.6%
Return on assets
-29.8%
Return on invested capital
0.00x
Asset turnover
-$4.1M
Cash from operations
$5.89
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025